The global anemia treatment market is on a steady growth path, with sales expected to exceed USD 10.0 billion in 2022.

Patients with symptomatic anemia associated with chronic kidney disease who are on chronic maintenance dialysis can now also ...

Efforts to develop a gene therapy for Diamond-Blackfan anemia (DBA) — a rare, life-threatening disorder in which bone marrow ...

Although not guideline-approved, screening for iron deficiency in patients with risk factors could prevent progression to ...

Now that the election is behind us, market watchers are digging into what Trump’s victory could mean for the economy in the coming months. As ...

While anemia impacts nearly a quarter of the world's population ... specifically when factoring in the under-detected ...

UCSF Benioff Children’s Hospital Oakland is enrolling patients in an innovative clinical trial that seeks to cure sickle cell ...

“With FDA clearance to begin clinical trials, HemaXellerate ™ has the potential to redefine the treatment landscape—not just for aplastic anemia but for a wide range of hematological disorders. This ...

FibroBiologics, Inc. (Nasdaq: FBLG) , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics ...

Tryvio (aprocitentan) is now available for difficult-to-control hypertension in combination with other antihypertensive drugs.

Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

RADNOR, PA — Idorsia Pharmaceuticals U.S. Inc. has announced the availability of TRYVIO™ (aprocitentan) in the United States ...